Intracavitary Spraying of Nanoregulator‐Encased Hydrogel Modulates Cholesterol Metabolism of Glioma‐Supportive Macrophage for Postoperative Glioblastoma Immunotherapy
Advanced Materials · 2024-03 · 36 (13)
DOI: 10.1002/adma.202311109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 28.12.2023. Verfasst von Yuanmin Dong und 23 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Departmen…. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Brain Neoplasms, Disaccharides. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: ISF-NSFC Joint Scientific Research Program, National Natural Science Foundation of China, Fundamental Research Funds of Shandong Province.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is notoriously resistant to immunotherapy due to its intricate immunosuppressive tumor microenvironment (TME). Dysregulated cholesterol metabolism is implicated in the TME and promotes tumor progression. Here, it is found that cholesterol levels in GBM tissues are abnormally high, and glioma‐supportive macrophages (GSMs), an essential “cholesterol factory”, demonstrate aberrantly hyperactive cholesterol metabolism and efflux, providing cholesterol to fuel GBM growth and induce CD8 + T cells exhaustion. Bioinformatics analysis confirms that high 7‐dehydrocholesterol reductase (DHCR7) level in GBM tissues associates with increased cholesterol biosynthesis, suppressed tumoricidal immune response, and poor patient survival, and DHCR7 expression level is significantly elevated in GSMs. Therefore, an intracavitary sprayable nanoregulator (NR)‐encased hydrogel system to modulate cholesterol metabolism of GSMs is reported. The degradable NR‐mediated ablation of DHCR7 in GSMs effectively suppresses cholesterol supply and activates T‐cell immunity. Moreover, the combination of Toll‐like receptor 7/8 (TLR7/8) agonists significantly promotes GSM polarization to antitumor phenotypes and ameliorates the TME. Treatment with the hybrid system exhibits superior antitumor effects in the orthotopic GBM model and postsurgical recurrence model. Altogether, the findings unravel the role of GSMs DHCR7/cholesterol signaling in the regulation of TME, presenting a potential treatment strategy that warrants further clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College…
- Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Jinan, Shandong Province, 250012, China.
- Harry W. and Charlotte Ullman Labov Chair in Cancer Studies, Fraunhofer Innovation Platform (FIP_DD@HUJI), Institute for Drug Research, The School of Pharmacy, Faculty of Medicine | Ein Karem Campus, The Hebrew Universi…
- Shandong Academy of Pharmaceutical Sciences, Jinan, Shandong Province, 250012, China.
- Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Jinan, Shandong Province, 250012, China.
- Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University, Jinan, Shandong, 250100, China.
ORCID-Profile: Ofra Benny, Xinyi Jiang
Förderung
- ISF-NSFC Joint Scientific Research Program
- National Natural Science Foundation of China
- Fundamental Research Funds of Shandong Province
- Shandong Provincial Key Research and Development Program (Major Scientific and Technological Innovation Project)
Zitieren
APA
Dong, Y., Zhang, J., Wang, Y., Zhang, Y., Rappaport, D., Yang, Z., Han, M., Liu, Y., Fu, Z., Zhao, X., Tang, C., Shi, C., Zhang, D., Li, D., Ni, S., Li, A., Cui, J., Li, T., Sun, P., …, & Jiang, X. (2024). Intracavitary Spraying of Nanoregulator‐Encased Hydrogel Modulates Cholesterol Metabolism of Glioma‐Supportive Macrophage for Postoperative Glioblastoma Immunotherapy. Advanced Materials, 36(13). https://doi.org/10.1002/adma.202311109
Vancouver
Dong Y, Zhang J, Wang Y, Zhang Y, Rappaport D, Yang Z, et al. Intracavitary Spraying of Nanoregulator‐Encased Hydrogel Modulates Cholesterol Metabolism of Glioma‐Supportive Macrophage for Postoperative Glioblastoma Immunotherapy. Advanced Materials. 2024;36(13). doi:10.1002/adma.202311109
BibTeX
@article{Dong2024,
author = {Dong, Yuanmin and Zhang, Jing and Wang, Yan and Zhang, Yulin and Rappaport, Daniella and Yang, Zhenmei and Han, Maosen and Liu, Ying and Fu, Zhipeng and Zhao, Xiaotian and Tang, Chunwei and Shi, Chongdeng and Zhang, Daizhou and Li, Dawei and Ni, Shilei and Li, Anning and Cui, Jiwei and Li, Tao and Sun, Peng and Benny, Ofra and Zhang, Cai and Zhao, Kun and Chen, Chen and Jiang, Xinyi},
title = {Intracavitary Spraying of Nanoregulator‐Encased Hydrogel Modulates Cholesterol Metabolism of Glioma‐Supportive Macrophage for Postoperative Glioblastoma Immunotherapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {13},
doi = {10.1002/adma.202311109}
}
EUVIMED